Related Experiment Videos
Pulmonary vascular disorders masquerading as interstitial lung disease
H M Sondheimer1, M C Lung, S M Brugman
1Department of Pediatrics, The Children's Hospital, University of Colorado Health Sciences Center, Denver, USA.
Pediatric Pulmonology
|November 1, 1995
Summary
A small percentage of children diagnosed with interstitial lung disease (ILD) actually have pulmonary vascular disorders, leading to severe illness. Early cardiac and pulmonary evaluation is crucial for accurate diagnosis in these critical pediatric cases.
Area of Science:
- Pediatric Pulmonology
- Pediatric Cardiology
- Vascular Biology
Background:
- Interstitial lung disease (ILD) in children can be challenging to diagnose.
- A subset of pediatric ILD cases may be misdiagnosed vascular disorders.
- Pulmonary vascular disorders in children are associated with high morbidity and mortality.
Purpose of the Study:
- To review the presentation, evaluation, and natural history of children initially diagnosed with ILD but found to have pulmonary vascular disorders.
- To develop a diagnostic strategy for differentiating ILD from pulmonary vascular disorders in children.
Main Methods:
- Retrospective review of 92 children with interstitial lung disease (ILD) over 14 years.
- Analysis of clinical presentation, diagnostic evaluations, and outcomes for a subgroup of 8 patients.
- Development of a cardiac and pulmonary evaluation protocol.
Main Results:
- Eight out of 92 children (9%) initially diagnosed with ILD were found to have pulmonary vascular disorders.
- This subgroup experienced very high morbidity and mortality, with only 3 of 8 survivors.
- The proposed evaluation strategy aided in the rapid identification of pulmonary vascular disorders.
Conclusions:
- Pulmonary vascular disorders should be considered in the differential diagnosis of pediatric interstitial lung disease (ILD).
- A focused cardiac and pulmonary evaluation strategy can improve the early detection of these critical conditions in children.
- Timely diagnosis and management of pediatric pulmonary vascular disorders are essential to improve patient outcomes.